Journal
CURRENT CARDIOLOGY REVIEWS
Volume 11, Issue 1, Pages 10-17Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573403X09666131117170446
Keywords
Cardiomyopathy; dilated; genetic counseling; genetics; medical; genetic testing; heart failure; pharmacogenetics
Categories
Funding
- NIH [U01HG006487, R01HL10412, HL096836]
- UAI Research Fellowship
- Leducq Foundation
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010412, R01HL104129, K08HL096836] Funding Source: NIH RePORTER
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006487] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The pathogenesis of heart failure involves a complex interaction between genetic and environmental factors. Genetic factors may influence the susceptibility to the underlying etiology of heart failure, the rapidity of disease progression, or the response to pharmacologic therapy. The genetic contribution to heart failure is relatively minor in most multi-factorial cases, but more direct and profound in the case of familial dilated cardiomyopathy. Early studies of genetic risk for heart failure focused on polymorphisms in genes integral to the adrenergic and renin-angiotensin-aldosterone system. Some of these variants were found to increase the risk of developing heart failure, and others appeared to affect the therapeutic response to neurohormonal antagonists. Regardless, each variant individually confers a relatively modest increase in risk and likely requires complex interaction with other variants and the environment for heart failure to develop. Dilated cardiomyopathy frequently leads to heart failure, and a genetic etiology increasingly has been recognized in cases previously considered to be idiopathic. Up to 50% of dilated cardiomyopathy cases without other cause likely are due to a heritable genetic mutation. Such mutations typically are found in genes encoding sarcomeric proteins and are inherited in an autosomal dominant fashion. In recent years, rapid advances in sequencing technology have improved our ability to diagnose familial dilated cardiomyopathy and those diagnostic tests are available widely. Optimal care for the expanding population of patients with heritable heart failure involves counselors and physicians with specialized training in genetics, but numerous online genetics resources are available to practicing clinicians.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available